Loading…
Underlying
Underlying Price
$8.36
Type
Call
Strike
11.5
Expiration
Nov 27, 2026
DTE
38d
Moneyness
OTM
Intrinsic
$0.00
IBRX 11.5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $0.05 | -82.14% | 7 | 143 |
| Oct 30, 2026 | 10d | $0.10 | -82.14% | 72 | 769 |
| Nov 6, 2026 | 17d | $0.35 | -38.60% | 2 | 39 |
| Nov 13, 2026 | 24d | $0.65 | +22.64% | 22 | 25 |
| Nov 27, 2026 | 38d | — | — | 0 | 0 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.